Phase 3 Obesity Trial, Recruiting NCT07226765 Sponsor: Amgen Condition: Obesity
Back to Obesity

Phase 3 Obesity Trial, Recruiting

NCT07226765
Recruiting Phase 3 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Your sleep study (overnight breathing test) must show that you stop breathing or have disrupted breathing at least 15 times per hour.
  • Your Body Mass Index (BMI) — a measure of weight relative to height — must be 27 or higher at the time of your initial check-up.
  • You must have tried to lose weight through diet and exercise at least once in the past without lasting success.
  • You must not have used a breathing machine (such as a CPAP machine) for at least 4 weeks before joining, and you must be unwilling or unable to use one, and not plan to use one during the study.

Who may not be able to join:

  • People who have previously had, or are planning to have, surgery on their upper airway for sleep apnea, or major surgery on their ears, nose, or throat.
  • People who have significant structural differences in the face or skull that may affect their breathing.
  • People whose sleep apnea is primarily caused by the brain not sending proper signals to breathe (central sleep apnea, 50% or more), or who have a specific breathing pattern during sleep called Cheyne Stokes Respiration.
  • People currently using any device or treatment for sleep apnea (such as a CPAP machine or mouth device) unless they are willing to stop using it before and throughout the study.
  • People with certain breathing conditions such as obesity-related breathing problems during the day, nerve or muscle diseases, or other health conditions that the study doctor believes could affect the trial results (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: MD, Amgen

Phone: 866-572-6436

Australian sites

Woolcock Institute of Medical Research, Macquarie Park, New South Wales
Royal Brisbane and Womens Hospital, Herston, Queensland
Monash Medical Centre, Clayton, Victoria

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Registry
ClinicalTrials.gov
Start date
25 November 2025
Est. completion
29 September 2027

Where this trial is recruiting

🇦🇺 Australia 🇧🇷 Brazil 🇨🇦 Canada 🇨🇿 Czechia 🇫🇷 France 🇩🇪 Germany 🇭🇺 Hungary 🇯🇵 Japan 🇵🇱 Poland 🇪🇸 Spain 🇺🇸 United States

3 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Change in Apnea-hypopnea Index (AHI) from baseline at Week 52

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov